A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The BENEDICT study is conducted to examine the effects of an ACE inhibitor, calcium channel blockade, a combination of these, and placebo, in the prevention of micro- and macro-albuminuria in Type 2 diabetic patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Abbott
• Treatments: Trandolapril; Verapamil

Criteria

Inclusion Criteria:

• Type 2 Diabetes

• Hypertension

Exclusion Criteria:

• Albuminuria (Phase A)

• Non-diabetic renal disease

• Subject has a hypersensitivity to ACE inhibitor, CCB